Kanabo Group (KNB) Competitors GBX 0.22 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock KNB vs. TLY, SPI, MGP, SBI, HEMO, ODX, MHC, GENI, VRCI, and BNRShould you be buying Kanabo Group stock or one of its competitors? The main competitors of Kanabo Group include Totally (TLY), Spire Healthcare Group (SPI), Medica Group (MGP), Sourcebio International (SBI), Hemogenyx Pharmaceuticals (HEMO), Omega Diagnostics Group (ODX), MyHealthChecked (MHC), GENinCode (GENI), Verici Dx (VRCI), and Burning Rock Biotech (BNR). These companies are all part of the "medical" sector. Kanabo Group vs. Its Competitors Totally Spire Healthcare Group Medica Group Sourcebio International Hemogenyx Pharmaceuticals Omega Diagnostics Group MyHealthChecked GENinCode Verici Dx Burning Rock Biotech Kanabo Group (LON:KNB) and Totally (LON:TLY) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, earnings, profitability, risk, media sentiment and valuation. Which has higher valuation and earnings, KNB or TLY? Totally has higher revenue and earnings than Kanabo Group. Kanabo Group is trading at a lower price-to-earnings ratio than Totally, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKanabo Group£1.14M1.25-£8.18M-£1.29-0.17Totally£133.05M0.00-£3.79M-£1.93-0.13 Which has more volatility and risk, KNB or TLY? Kanabo Group has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500. Comparatively, Totally has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Do institutionals & insiders believe in KNB or TLY? 3.8% of Kanabo Group shares are owned by institutional investors. Comparatively, 51.3% of Totally shares are owned by institutional investors. 37.0% of Kanabo Group shares are owned by company insiders. Comparatively, 13.3% of Totally shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is KNB or TLY more profitable? Totally has a net margin of -2.85% compared to Kanabo Group's net margin of -717.63%. Totally's return on equity of -11.01% beat Kanabo Group's return on equity.Company Net Margins Return on Equity Return on Assets Kanabo Group-717.63% -121.77% -20.89% Totally -2.85%-11.01%-2.42% Do analysts rate KNB or TLY? Totally has a consensus price target of GBX 20, indicating a potential upside of 7,900.00%. Given Totally's stronger consensus rating and higher possible upside, analysts plainly believe Totally is more favorable than Kanabo Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kanabo Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Totally 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor KNB or TLY? In the previous week, Totally had 5 more articles in the media than Kanabo Group. MarketBeat recorded 5 mentions for Totally and 0 mentions for Kanabo Group. Totally's average media sentiment score of 0.31 beat Kanabo Group's score of 0.00 indicating that Totally is being referred to more favorably in the news media. Company Overall Sentiment Kanabo Group Neutral Totally Neutral SummaryTotally beats Kanabo Group on 12 of the 16 factors compared between the two stocks. Get Kanabo Group News Delivered to You Automatically Sign up to receive the latest news and ratings for KNB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding KNB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KNB vs. The Competition Export to ExcelMetricKanabo GroupMedical Care Facilities IndustryMedical SectorLON ExchangeMarket Cap£1.42M£1.58B£5.52B£2.96BDividend YieldN/A4.04%5.24%5.02%P/E Ratio-0.177.0627.19150.20Price / Sales1.2514.19395.22239,811.95Price / Cash1.8212.3226.2127.97Price / Book0.242.067.924.54Net Income-£8.18M£58.06M£3.17B£5.90B7 Day PerformanceN/A0.91%1.79%1.41%1 Month PerformanceN/A4.24%1.28%4.64%1 Year Performance-82.56%49.47%33.32%79.64% Kanabo Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KNBKanabo GroupN/AGBX 0.23flatN/AN/A£1.42M£1.14M-0.1720TLYTotally2.9605 of 5 starsGBX 0.25+4.2%GBX 20+7,900.0%-96.7%£491K£133.05M-0.131,668Gap DownSPISpire Healthcare GroupN/AGBX 226.98+1.6%GBX 300+32.2%-6.0%£911.49M£1.44B32.31420Gap UpMGPMedica GroupN/AN/AN/AN/A£259.85M£76.98M3,516.671,212SBISourcebio InternationalN/AN/AN/AN/A£85.31M£75.61M1,277.78194Gap UpHigh Trading VolumeHEMOHemogenyx PharmaceuticalsN/AGBX 155.99+1.8%N/A+11,396.0%£5.56MN/A-797.9714Gap UpODXOmega Diagnostics GroupN/AN/AN/AN/A£5.23M£7.55M-220.0091Gap DownMHCMyHealthCheckedN/AGBX 10-7.0%N/A+10.0%£5.20M£9.43M-4.9916Negative NewsGap DownGENIGENinCodeN/AGBX 2.34+4.0%N/A-71.1%£4.15M£2.67M-0.682,300Positive NewsGap UpVRCIVerici DxN/AGBX 1.25+11.1%N/A-84.2%£3.79M£5.91M-0.7219Gap DownBNRBurning Rock BiotechN/AN/AN/AN/A£3.77MN/A0.001,390Gap DownHigh Trading Volume Related Companies and Tools Related Companies Totally Alternatives Spire Healthcare Group Alternatives Medica Group Alternatives Sourcebio International Alternatives Hemogenyx Pharmaceuticals Alternatives Omega Diagnostics Group Alternatives MyHealthChecked Alternatives GENinCode Alternatives Verici Dx Alternatives Burning Rock Biotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:KNB) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kanabo Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Kanabo Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KNB Stock Alerts